Harbin Pharma to Acquire 40% of US-based GNC for $300M
February 13, 2018 -- Harbin Pharmaceutical. will invest $300 million in GNC Holdings (NYSE: GNC), a US company that makes nutritional supplements. Hayao will also form a JV with GNC to make and distribute GNC supplements in China. After the transaction, Hayao will be GNC's largest shareholder with a 40% stake in the company. GNC shares rose 27% on the news, climbing to $5.35 per share.